Similar to what was found in all participant, HW phenotype was associated with ER+/PR+ breast cancer, with a 95% (OR = 1.95, 95% CI:1.21–3.13) increase in risk for women with a positive HW phenotype. Here, ESR1 is linked to breast cancer.